Verona Pharma Newsroom

Verona Pharma Is Maintained at Buy by Truist Securities

Dow JonesOct 10 00:37

Verona Pharma Analyst Ratings

BenzingaOct 10 00:27

Truist Financial Maintains Verona Pharma(VRNA.US) With Buy Rating, Announces Target Price $38

Futu NewsOct 9 19:31

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Verona Pharma (VRNA) and Hims & Hers Health (HIMS)

TipRanksOct 9 19:22

Piper Sandler Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Futu NewsOct 3 19:31

Piper Sandler Remains a Buy on Verona Pharma (VRNA)

TipRanksOct 3 18:47

Wells Fargo Initiates Verona Pharma(VRNA.US) With Buy Rating, Announces Target Price $50

Futu NewsOct 3 18:31

Wells Fargo Initiates Verona Pharma at Overweight With $50 Price Target

MT NewswiresOct 3 18:27

H.C. Wainwright Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Futu NewsOct 1 18:31

HC Wainwright & Co. Reiterates Buy on Verona Pharma, Maintains $36 Price Target

BenzingaSep 17 23:39

Verona Pharma Analyst Ratings

BenzingaSep 17 23:38

H.C. Wainwright Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Futu NewsSep 17 22:31

Buy Rating Affirmed for Verona Pharma Amid Strategic Partnership and Market Potential for Novel COPD Treatment

TipRanksSep 17 21:49

H.C. Wainwright Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Futu NewsSep 11 20:33

Verona Pharma Analyst Ratings

BenzingaSep 11 19:37

HC Wainwright & Co. Reiterates Buy on Verona Pharma, Maintains $36 Price Target

BenzingaSep 11 19:37

Truist Financial Maintains Verona Pharma(VRNA.US) With Buy Rating

Futu NewsSep 9 19:31

Verona Pharma (VRNA) Receives a Buy From Truist Financial

TipRanksSep 9 19:19

Piper Sandler Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Futu NewsAug 22 19:33

Piper Sandler Sticks to Its Buy Rating for Verona Pharma (VRNA)

TipRanksAug 22 18:47